Terug
55
44
36
17
50
40
Dagbereik
€ 14,69
€ 15,42
52-Weeksbereik
€ 13,00
€ 19,90
Volume
201.575
50D / 200D Gem.
€ 14,37
/
€ 15,12
Vorige Slotkoers
€ 15,49
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1,9 | 10,5 |
| P/B | 0,3 | 1,2 |
| ROE % | 16,2 | 12,3 |
| Net Margin % | 20,4 | 5,3 |
| Rev Growth 5Y % | 20,5 | 5,5 |
| D/E | 0,6 | 0,6 |
Koersdoel Analisten
Hold
€ 16,33
+7.7%
Low: € 16,00
High: € 17,00
Forward K/W
1,62
Forward WPA
€ 9,37
WPA Groei (sch.)
+0,0%
Omzet Sch.
3,99B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 0,00
€ 0,00 – € 0,00
|
4,35B | 1 |
| FY2027 |
€ 10,84
€ 10,35 – € 11,32
|
4,27B | 3 |
| FY2026 |
€ 9,37
€ 8,95 – € 9,74
|
3,99B | 3 |
No quarterly estimates available
Dividend History
1 yr streakYield
0,02%
Payout Ratio
0,16%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 25, 2026 | Apr 06, 2026 | € 0,66 | 4,33% |
| Mar 26, 2025 | Apr 04, 2025 | € 0,23 | 1,29% |
Belangrijkste Punten
Revenue grew 20,50% annually over 5 years — strong growth
Earnings grew 16,81% over the past year
ROE of 16,18% — decent returns on equity
Net margin of 20,35% shows strong profitability
Generating 1,04B in free cash flow
P/E of 1,86 — trading at a low valuation
Groei
Revenue Growth (5Y)
20,50%
Revenue (1Y)9,69%
Earnings (1Y)16,81%
FCF Growth (3Y)13,95%
Kwaliteit
Return on Equity
16,18%
ROIC11,20%
Net Margin20,35%
Op. Margin32,81%
Veiligheid
Debt / Equity
0,64
Current Ratio2,20
Interest Coverage2,41
Waardering
P/E Ratio
1,86
Forward P/E1,62
P/B Ratio0,28
EV/EBITDA2,83
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,69% | Revenue Growth (3Y) | 12,26% |
| Earnings Growth (1Y) | 16,81% | Earnings Growth (3Y) | 38,18% |
| Revenue Growth (5Y) | 20,50% | Earnings Growth (5Y) | 34,81% |
| Profitability | |||
| Revenue (TTM) | 3,62B | Net Income (TTM) | 737,68M |
| ROE | 16,18% | ROA | 7,89% |
| Gross Margin | 64,46% | Operating Margin | 32,81% |
| Net Margin | 20,35% | Free Cash Flow (TTM) | 1,04B |
| ROIC | 11,20% | FCF Growth (3Y) | 13,95% |
| Safety | |||
| Debt / Equity | 0,64 | Current Ratio | 2,20 |
| Interest Coverage | 2,41 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,16% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 1 yrs | ||
| Valuation | |||
| P/E Ratio | 1,86 | Forward P/E | 1,62 |
| P/B Ratio | 0,28 | P/S Ratio | 0,38 |
| PEG Ratio | 0,63 | Forward PEG | N/A |
| EV/EBITDA | 2,83 | Fwd EV/EBITDA | 2,31 |
| Forward P/S | 0,34 | Fwd Earnings Yield | 61,73% |
| FCF Yield | 75,57% | ||
| Market Cap | 1,37B | Enterprise Value | 3,37B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,62B | 3,30B | 2,88B | 2,33B | 1,72B |
| Net Income | 737,68M | 631,51M | 386,32M | 373,57M | 223,33M |
| EPS (Diluted) | 8,11 | 6,93 | 4,27 | 4,15 | 2,37 |
| Gross Profit | 2,34B | 2,09B | 1,77B | 1,47B | 1,07B |
| Operating Income | 1,19B | 1,01B | 767,06M | 664,10M | 440,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9,35B | 8,83B | 7,58B | 7,20B | 6,45B |
| Total Liabilities | 4,46B | 4,52B | 3,94B | 3,95B | 3,45B |
| Shareholders' Equity | 4,85B | 4,27B | 3,60B | 3,20B | 2,95B |
| Total Debt | 3,12B | 3,17B | 2,68B | 2,71B | 2,16B |
| Cash & Equivalents | 1,12B | 911,02M | 553,03M | 1,09B | 748,56M |
| Current Assets | 1,94B | 1,59B | 1,20B | 1,64B | 1,21B |
| Current Liabilities | 883,60M | 1,14B | 1,06B | 905,69M | 766,51M |
Strategiescores
This stock passed the criteria for 6 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#299 of 1052
Custom
Capital Light Compounder
#95 of 218
#298 of 618
#457 of 670
Custom
Balanced Risk
#51 of 151
Custom
Lower Risk
#99 of 140
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Balanced Risk
Mar 24, 2026
Ingestapt
Lower Risk
Mar 24, 2026
